Summary
87 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 24 USD is left as net profit.
- Revenue grew by 26% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 22% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.0 USD for 1 USD of yearly profit. Over the last five years it was 14.9 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 33% a year over 5 years. Over the last 3 years it grew by 26% a year. For the next fiscal year analysts expect revenue to fall by 22%. Earnings per share grew by 6.1% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 34 USD
- Sales and administration 36 USD
- Taxes and other 7.2 USD
- Net profit 24 USD
Net profit, industry median (Banks - Regional) 21 USD
Out of every 100 USD of revenue, 24 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 7.00%
- Paid out of profit
- 70%
You receive $1.75 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 5
- Hold 7
- Sell 0
No analyst has published a price target.
42% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.